New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Fighting cancer with LIGHT, a novel proton accelerator for treatment

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb
Oncology January 29,2024
Fighting cancer with LIGHT, a novel proton accelerator for treatment

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb
Oncology January 29,2024
New study presents evidence for 'tough conversations' around racism in access to cancer care

New study presents evidence for 'tough conversations' around racism in access to cancer care

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research in the November 2022 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkhas examined w
Oncology January 29,2024
New study presents evidence for 'tough conversations' around racism in access to cancer care

New study presents evidence for 'tough conversations' around racism in access to cancer care

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research in the November 2022 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkhas examined w
Oncology January 29,2024
Using AI during cancer-screening results in more recommended controls

Using AI during cancer-screening results in more recommended controls

by Mathilde Coraline Aarvold Bakke,University of OsloGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.08.022A polyp is a small growt
Oncology January 29,2024
Using AI during cancer-screening results in more recommended controls

Using AI during cancer-screening results in more recommended controls

by Mathilde Coraline Aarvold Bakke,University of OsloGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.08.022A polyp is a small growt
Oncology January 29,2024
Targeted care reverses racial/ethnic health disparities in colon cancer screening, researchers find

Targeted care reverses racial/ethnic health disparities in colon cancer screening, researchers find

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCredit: Pixabay/CC0 Public DomainColorectal cancer is a leading cancer-related cause of death in the United States, ranking third in in
Oncology January 29,2024
Targeted care reverses racial/ethnic health disparities in colon cancer screening, researchers find

Targeted care reverses racial/ethnic health disparities in colon cancer screening, researchers find

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCredit: Pixabay/CC0 Public DomainColorectal cancer is a leading cancer-related cause of death in the United States, ranking third in in
Oncology January 29,2024
Study: Living in disadvantaged neighborhood shortens breast cancer survival

Study: Living in disadvantaged neighborhood shortens breast cancer survival

by Lori SolomonBreast cancer-specific survival is shorter in women from disadvantaged neighborhoods versus advantaged neighborhoods, according to a study published online April 21 inJAMA Network
Oncology January 29,2024
Study: Living in disadvantaged neighborhood shortens breast cancer survival

Study: Living in disadvantaged neighborhood shortens breast cancer survival

by Lori SolomonBreast cancer-specific survival is shorter in women from disadvantaged neighborhoods versus advantaged neighborhoods, according to a study published online April 21 inJAMA Network
Oncology January 29,2024
Drug combination provides a one-two punch attack against colorectal cancer

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the
Oncology January 29,2024
Drug combination provides a one-two punch attack against colorectal cancer

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the
Oncology January 29,2024
A simple antibacterial treatment can solve a severe skin problem caused by radiation therapy

A simple antibacterial treatment can solve a severe skin problem caused by radiation therapy

byAlbert Einstein College of MedicineA new study inJAMA Oncologyfound that a simple antibacterial treatment prevents severe cases of radiation dermatitis (ARD): No patients in the tr
Oncology January 29,2024
A simple antibacterial treatment can solve a severe skin problem caused by radiation therapy

A simple antibacterial treatment can solve a severe skin problem caused by radiation therapy

byAlbert Einstein College of MedicineA new study inJAMA Oncologyfound that a simple antibacterial treatment prevents severe cases of radiation dermatitis (ARD): No patients in the tr
Oncology January 29,2024
Researchers identify a regulator of breast cancer development

Researchers identify a regulator of breast cancer development

by UT Southwestern Medical CenterBreast cancer stem cells (BCSCs) are responsible for breast carcinogenesis. Researchers' work reveals potential targets for killing BCSCs to prevent breast tu
Oncology January 29,2024
Researchers identify a regulator of breast cancer development

Researchers identify a regulator of breast cancer development

by UT Southwestern Medical CenterBreast cancer stem cells (BCSCs) are responsible for breast carcinogenesis. Researchers' work reveals potential targets for killing BCSCs to prevent breast tu
Oncology January 29,2024
No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma
Oncology January 29,2024
No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma
Oncology January 29,2024
Exercise could reduce frailty in the most common form of leukemia

Exercise could reduce frailty in the most common form of leukemia

by University of SurreyCredit: Pixabay/CC0 Public DomainIncreased levels of exercise could help reduce frailty in patients with the most common form of leukemia, chronic lymphocytic (CLL), accord
Oncology January 29,2024
Exercise could reduce frailty in the most common form of leukemia

Exercise could reduce frailty in the most common form of leukemia

by University of SurreyCredit: Pixabay/CC0 Public DomainIncreased levels of exercise could help reduce frailty in patients with the most common form of leukemia, chronic lymphocytic (CLL), accord
Oncology January 29,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com